Orotidine

CAS: 314-50-1

Ref. TR-O691520

Produktinformation

• Name: Orotidine
• Synonyme: 4-Pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-3-ß-D-ribofuranosyl-, Orotidine (6CI,7CI,8CI), 1,2,3,6-Tetrahydro-2,6-dioxo-3-ß-D-ribofuranosyl-4-pyrimidinecarboxylic acid, 6-Carboxyuridine, Orotic acid riboside, 1,2,3,6-Tetrahydro-2,6-dioxo-3-β-<span class="text-smallcaps">D</span>-ribofuranosyl-4-pyrimidinecarboxylic acid, 3-Ribofuranosylorotic acid, 4-Pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-3-beta-D-ribofuranosyl-, 4-Pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-3-β-<span class="text-smallcaps">D</span>-ribofuranosyl-, 1,2,3,6-Tetrahydro-2,6-dioxo-3-β-D-ribofuranosyl-4-pyrimidinecarboxylic acid, 4-Pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-3-β-D-ribofuranosyl-

Beschreibung

Applications Orotidine is a metabolite of Orotic Acid (O691500); a compound used in the preparation of therapeutic agents for chronic obstructive pulmonary disease (COPD) treatment.
References Pausch, J., et al.: Verhandlungen der Deutschen Gesellschaft fuer Innere Medizin, 86, 805 (1980); Burgess, K., et al.: Rapid Commun. Mass. Sp., 25, 3447 (2011)

• Marke: TRC

Chemische Eigenschaften

• Molekulargewicht: 288.21
• Formel: C₁₀H₁₂N₂O₈
• Farbe/Form: Neat
• InChl: InChI=1S/C10H12N2O8/c13-2-4-6(15)7(16)8(20-4)12-3(9(17)18)1-5(14)11-10(12)19/h1,4,6-8,13,15-16H,2H2,(H,17,18)(H,11,14,19)/t4-,6-,7-,8-/m1/s1
• InChI Key: InChIKey=FKCRAVPPBFWEJD-XVFCMESISA-N
• SMILES: O=C(O)c1cc(=O)[nH]c(=O)n1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O